Observational studyInternal and emergency medicine2026
Optimal heart rate in patients with atrial fibrillation: insights from the COOL-AF registry.
Observational study in Internal and emergency medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Heart rate control is an important strategy for the management of patients with atrial fibrillation (AF). However, there remains some uncertainty for the optimal target heart rate of AF patients. COOL-AF was a prospective multicenter registry of patients with non-valvular AF. Patients were followed-up every 6 months until 3 years. The primary outcome was the composite of cardiovascular death, heart failure, and ischemic stroke/systemic embolism (SSE). A total of 3405 patients were studied (mean age 67.8 ± 11.3 years; 41.8% female). Mean heart rate was 77.4 ± 16.2 bpm. Number of patients with baseline heart rate < 60, 60-80, 80-100, and ≥ 100 bpm was 371 (10.9%), 1616 (47.4%), 1116 (32.8%), and 302 (8.9%), respectively. The overall incidence rates of the composite outcome, heart failure event, CV death, and SSE were 4.97 (4.51-5.47), 2.84 (2.49-3.21), 1.34 (1.11-1.60), and 1.51 (1.26-1.78) per 100 person-years, respectively. When compared to those with heart rate in the range 60-80 bpm, AF patient with heart rate > 100 bpm had the highest incidence rate of the composite outcome (7.06 per 100 person-years) with the unadjusted and adjusted hazard ratios (95%CI) of 1.59 (1.17, 2.16) (p = 0.003) and 1.51 (1.11-2.07) (p = 0.009), respectively. The analysis of dynamic changes in heart rate demonstrated more prominent results with the unadjusted and adjusted hazard ratios (95%CI) of 1.84 (1.40, 2.40) (p < 0.001) and 1.76 (1.34-2.37) (p < 0.001), respectively. In conclusion, there is a J-curve pattern for the relation of baseline resting heart rate and the composite outcome in patients with AF. Patients with heart rate greater than 100 are the highest risk group.
Indexed as
Identifiers
41559252What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.